<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>衡道病理 | wechat-feeds</title><link>http://MzA5MzM4NzM0Nw.favicon.privacyhide.com/favicon.ico</link><description>精准诊断 呵护生命 — 衡道病理旗下的官方医学新媒体。 提供一站式病理医学学习交流平台，传播精彩课程、分享精彩案例、促进人文交流、推动行业发展。</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 15 Jun 2021 21:27:45 +0800</pubDate><image><url>http://MzA5MzM4NzM0Nw.favicon.privacyhide.com/favicon.ico</url><title>衡道病理 | wechat-feeds</title><link>http://MzA5MzM4NzM0Nw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>【衡道丨干货】纤维母细胞和肌纤维母细胞性肿瘤（上）</title><link>https://mp.weixin.qq.com/s/od0OHW5xiQpmYuwo6jJjAQ</link><description></description><content:encoded><![CDATA[【衡道丨干货】纤维母细胞和肌纤维母细胞性肿瘤（上）]]></content:encoded><pubDate>Tue, 15 Jun 2021 17:52:53 +0800</pubDate></item><item><title>衡道病理恭祝广大病理同仁端午安康！</title><link>https://mp.weixin.qq.com/s/COi8aJ8Js5LqClOGSGaCDw</link><description></description><content:encoded><![CDATA[衡道病理恭祝广大病理同仁端午安康！]]></content:encoded><pubDate>Mon, 14 Jun 2021 12:02:51 +0800</pubDate></item><item><title>【衡道丨课程】精选三甲现场——浅谈肾脏占位之MIT家族那些事</title><link>https://mp.weixin.qq.com/s/NCLzvqzFRdTaHOjdgTQsZA</link><description></description><content:encoded><![CDATA[【衡道丨课程】精选三甲现场——浅谈肾脏占位之MIT家族那些事]]></content:encoded><pubDate>Fri, 11 Jun 2021 18:04:32 +0800</pubDate></item><item><title>【衡道丨干货】脱钙组织的IHC检测</title><link>https://mp.weixin.qq.com/s/bphFiiksY30K73fRRqgClg</link><description></description><content:encoded><![CDATA[【衡道丨干货】脱钙组织的IHC检测]]></content:encoded><pubDate>Thu, 10 Jun 2021 17:46:45 +0800</pubDate></item><item><title>【衡道丨干货】2021 CSCO胃癌诊断指南共识</title><link>https://mp.weixin.qq.com/s/WlPv3lZCw0oX01Sq1Dcc8g</link><description></description><content:encoded><![CDATA[【衡道丨干货】2021 CSCO胃癌诊断指南共识]]></content:encoded><pubDate>Wed, 09 Jun 2021 18:03:15 +0800</pubDate></item><item><title>【衡道丨直播】三甲病理现场：以点带面，临床病理共话「恶黑」</title><link>https://mp.weixin.qq.com/s/betTO31IT5ZbfcIjG9rJGw</link><description></description><content:encoded><![CDATA[【衡道丨直播】三甲病理现场：以点带面，临床病理共话「恶黑」]]></content:encoded><pubDate>Tue, 08 Jun 2021 17:14:02 +0800</pubDate></item><item><title>新闻丨“衡道病理”官网全新升级并启用新域名！</title><link>https://mp.weixin.qq.com/s/lLlDAdDlW-nUQJfG7Dh0NA</link><description></description><content:encoded><![CDATA[新闻丨“衡道病理”官网全新升级并启用新域名！]]></content:encoded><pubDate>Tue, 08 Jun 2021 17:14:02 +0800</pubDate></item><item><title>【衡道丨干货】我眼中的“ASCUS”</title><link>https://mp.weixin.qq.com/s/oBUsk38y5o4-MH4RURkyVA</link><description></description><content:encoded><![CDATA[【衡道丨干货】我眼中的“ASCUS”]]></content:encoded><pubDate>Mon, 07 Jun 2021 18:03:27 +0800</pubDate></item><item><title>【衡道丨推荐】衡道研习社有奖问卷调查：想在衡道研习社听什么课，我们听您的</title><link>https://mp.weixin.qq.com/s/qLYUpAjangIkXG9TN99KNQ</link><description></description><content:encoded><![CDATA[【衡道丨推荐】衡道研习社有奖问卷调查：想在衡道研习社听什么课，我们听您的]]></content:encoded><pubDate>Fri, 04 Jun 2021 18:44:52 +0800</pubDate></item><item><title>【衡道丨干货】直接免疫组化的原理与优势</title><link>https://mp.weixin.qq.com/s/Vp8CnDFGz3Wgk380DnS7Dg</link><description></description><content:encoded><![CDATA[【衡道丨干货】直接免疫组化的原理与优势]]></content:encoded><pubDate>Thu, 03 Jun 2021 15:09:28 +0800</pubDate></item><item><title>【衡道丨干货】2021 CSCO乳腺癌诊断指南共识</title><link>https://mp.weixin.qq.com/s/Ry0ZvdWCc3zDY5QpSRj6Xw</link><description></description><content:encoded><![CDATA[【衡道丨干货】2021 CSCO乳腺癌诊断指南共识]]></content:encoded><pubDate>Wed, 02 Jun 2021 18:03:46 +0800</pubDate></item></channel></rss>